MYGN icon

Myriad Genetics
MYGN

Upgrade to unlock
Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$8
35% upside
High target

4 analyst ratings

positive
3  neutral
75%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Piper Sandler
Piper Sandler
Dave Weiner
33% 1-yr MYGN win rate
11 Nov ‘25 2 months ago
Wells Fargo
Wells Fargo
Brandon Couillard
5 Nov ‘25 2 months ago
TD Cowen
TD Cowen
Daniel Brennan
4 Nov ‘25 2 months ago
UBS
UBS
Lu Li
4 Nov ‘25 2 months ago